Literature DB >> 24942019

Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease.

Lauren M Beverung1, James W Varni, Julie A Panepinto.   

Abstract

Health-related quality of life (HRQL) measures provide information about disease assessment; however, health care providers may be reluctant to use HRQL assessments as scores can be difficult to interpret. We sought to identify levels for impaired pain-related HRQL in children with sickle cell disease (SCD). Children (n=251) completed the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales and PedsQL SCD Module in a multisite study. Using children's item scores on the Pain and Hurt and Pain Impact scales of the PedsQL SCD Module, High, Intermediate, and Low Functioning groups were created. We compared functioning groups with the Pain and Hurt and Pain Impact scale scores to determine levels representing high and low HRQL. These scores were compared with disease severity and the PedsQL Generic Core Scales. Scores of ≤60 on the PedsQL SCD Pain and Hurt and Pain Impact scales were associated with severe disease and met requirements for impaired functioning on the PedsQL Generic Core Scales. Scores of ≥81 on the Pain and Hurt and the Pain Impact scales can be considered consistent with good HRQL in those domains in SCD. Alternately, scores of ≤60 are cause for concern and suggest areas of HRQL impairment in SCD.

Entities:  

Mesh:

Year:  2015        PMID: 24942019      PMCID: PMC4269583          DOI: 10.1097/MPH.0000000000000177

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  14 in total

Review 1.  Health-related quality of life in sickle cell disease.

Authors:  Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

2.  Health-related quality of life of severely obese children and adolescents.

Authors:  Jeffrey B Schwimmer; Tasha M Burwinkle; James W Varni
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

3.  Symptoms and quality of life indicators among children with chronic medical conditions.

Authors:  Jiseon Kim; Hyewon Chung; Dagmar Amtmann; Rana Salem; Ryoungsun Park; Robert L Askew
Journal:  Disabil Health J       Date:  2013-10-12       Impact factor: 2.554

4.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

5.  Factor analysis, causal indicators and quality of life.

Authors:  P M Fayers; D J Hand
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

Review 6.  Health-related quality of life in sickle cell disease: past, present, and future.

Authors:  Julie A Panepinto; Melanie Bonner
Journal:  Pediatr Blood Cancer       Date:  2012-04-22       Impact factor: 3.167

7.  PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

Authors:  Julie A Panepinto; Sylvia Torres; Cristiane B Bendo; Timothy L McCavit; Bogdan Dinu; Sandra Sherman-Bien; Christy Bemrich-Stolz; James W Varni
Journal:  Pediatr Blood Cancer       Date:  2013-02-25       Impact factor: 3.167

8.  The clinical utility of health-related quality of life assessment in pediatric cardiology outpatient practice.

Authors:  Karen Uzark; Eileen King; Robert Spicer; Robert Beekman; Thomas Kimball; James W Varni
Journal:  Congenit Heart Dis       Date:  2012-09-12       Impact factor: 2.007

9.  The performance of the PedsQL generic core scales in children with sickle cell disease.

Authors:  Julie A Panepinto; Nicholas M Pajewski; Lisa M Foerster; Raymond G Hoffmann
Journal:  J Pediatr Hematol Oncol       Date:  2008-09       Impact factor: 1.289

10.  The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity.

Authors:  James W Varni; Tasha M Burwinkle; Michael Seid; Douglas Skarr
Journal:  Ambul Pediatr       Date:  2003 Nov-Dec
View more
  19 in total

1.  Brief Screening Measures Identify Risk for Psychological Difficulties Among Children with Sickle Cell Disease.

Authors:  Anna M Hood; Ilana Reife; Allison A King; Desiree A White
Journal:  J Clin Psychol Med Settings       Date:  2020-12

2.  Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease.

Authors:  Arlene Smaldone; Deepa Manwani; Nancy S Green
Journal:  Pediatr Blood Cancer       Date:  2019-04-02       Impact factor: 3.167

3.  Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.

Authors:  Lauren M Beverung; John J Strouse; Monica L Hulbert; Kathleen Neville; Robert I Liem; Baba Inusa; Beng Fuh; Allison King; Emily Riehm Meier; James Casella; Michael R DeBaun; Julie A Panepinto
Journal:  Am J Hematol       Date:  2015-02       Impact factor: 10.047

4.  Empirically Derived Profiles of Health-Related Quality of Life in Youth and Young Adults with Sickle Cell Disease.

Authors:  Mary E Keenan; Megan Loew; Kristoffer S Berlin; Jason Hodges; Nicole M Alberts; Jane S Hankins; Jerlym S Porter
Journal:  J Pediatr Psychol       Date:  2021-03-18

5.  The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia.

Authors:  Courtney D Fitzhugh; Mark C Walters
Journal:  Blood Adv       Date:  2017-12-08

6.  HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease.

Authors:  Arlene Smaldone; Sally Findley; Deepa Manwani; Haomiao Jia; Nancy S Green
Journal:  J Pediatr       Date:  2018-03-20       Impact factor: 4.406

7.  Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant.

Authors:  Deepika S Darbari; Jaquette Liljencrantz; Austin Ikechi; Staci Martin; Marie Claire Roderick; Courtney D Fitzhugh; John F Tisdale; Swee Lay Thein; Matthew Hsieh
Journal:  Br J Haematol       Date:  2018-03-12       Impact factor: 6.998

Review 8.  What is the future of patient-reported outcomes in sickle-cell disease?

Authors:  Sharon A Singh; Nitya Bakshi; Prashant Mahajan; Claudia R Morris
Journal:  Expert Rev Hematol       Date:  2020-10-15       Impact factor: 2.929

9.  Clinical meaning of PROMIS pain domains for children with sickle cell disease.

Authors:  Ashima Singh; Julie A Panepinto
Journal:  Blood Adv       Date:  2019-08-13

10.  Hemoglobin F as a predictor of health-related quality of life in children with sickle cell anemia.

Authors:  Mohamed-Rachid Boulassel; Amira Al-Badi; Mohamed Elshinawy; Juhaina Al-Hinai; Muna Al-Saadoon; Zahra Al-Qarni; Hammad Khan; Rizwan Nabi Qureshi; Yasser Wali
Journal:  Qual Life Res       Date:  2018-10-22       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.